SEARCH

SEARCH BY CITATION

References

  • 1
    Zhang W-H, Alexander S, Bouvier-Colle M-H, Macfarlane A; the MOMS-B Group. Incidence of severe pre-eclampsia, postpartum haemorrhage as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG 2005;102:8996.
  • 2
    Brace V, Penney G, Hall M. Quantifying severe maternal morbidity: a Scottish population study. BJOG 2004;111:4814.
  • 3
    Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322:108993.
  • 4
    Bouvier-Colle MH, Ould EJ, Varnoux N, Goffinet F, Alexander S, Bayoumeu F, et al. Evaluation of the quality of care for severe obstetrical haemorrhage in three French regions. BJOG 2001;108:898903.
  • 5
    The EUPHRATES* Group. European Consensus on Prevention and Management of Post Partum Haemorrhage, 2005. [www.euphrates.inserm.fr/inserm/euphrates.nsf/AllDocumentsByUNID/95A14F46F31A5246C125707400485AED?OpenDocument&l=3.1]. Accessed 25 March 2007.
  • 6
    Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour (Cochrane Review). Cochrane Database Syst Rev 2000;CD000007. DOI: 10.1002/14651858.CD000007.
  • 7
    McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004; CD000201. DOI: 10.1002/14651858.CD000201.pub2.
  • 8
    Cotter A, Ness A, Tolosa J. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev 2001;CD001808. DOI: 10.1002/14651858.CD001808.
  • 9
    Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2004; CD000494. DOI: 10.1002/14651858.CD000494.pub2.
  • 10
    McDonald SJ, Abbott JM. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes (Protocol). Cochrane Database Syst Rev 2003; CD004074. DOI: 10.1002/14651858.CD004074.
  • 11
    Huh WK, Chelmow D, Malone FD. A double blinded, randomized controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention postpartum hemorrhage. Gynecol Obstet Invest 2004;58:726.
  • 12
    Jackson KW Jr, Allbert JR, Schemmer GK, Elliot M, Humphrey A, Taylor J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 2001;185:8737.
  • 13
    Soltani H, Dickinson F, Symonds I. Placental cord drainage after spontaneous vaginal delivery as part of the management of the third stage of labour. Cochrane Database Syst Rev 2005; CD004665. DOI: 10.1002/14651858.CD004665.pub2.
  • 14
    Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2003; CD003249. DOI: 10.1002/14651858.CD003249.
  • 15
    Mousa HA, Alfirevic Z. Major postpartum hemorrhage: survey of maternity units in the United Kingdom. Acta Obstet Gynecol Scand 2002;81:72730.
  • 16
    American Academy of Family Physicians. ALSO Instructors Manual. University of Wisconsin, 2004.
  • 17
    Ndala R. Cephalopelvic disproportion, obstructed labour and other obstetric emergencies. In: StableD, RankinJ, editors. Physiology in Childbearing, 2nd edn. London: Elsevier; 2005. pp. 56574.
  • 18
    Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004–2006. Int J Gynaecol Obstet 2006;94:24353.
  • 19
    Festin MR, Lumbignanon P, Tolosa JE, Finney KA, Ba-Thike K, Chipato T, et al. International survey on variations in practice of the management of the third stage of labour. Bull World Health Organ 2003;81:28691.
  • 20
    Alfirevic Z, Edwards G, Platt MJ. The impact of delivery suite guidelines in the intrapartum care in ‘standard primigravida’. Eur J Obstet Gynecol Reprod Biol 2004;115:2831.
  • 21
    Penney G, Adamson L, Kerhaghan D. Scottish Audit of Severe Maternal Morbidity. Second Annual Report 2004. Aberdeen: SPCERCH, 2005.